Targeting Leukotrienes in Kidney Disease

Targeting Leukotrienes in Kidney Disease
Condition:   Diabetic Kidney Disease
Intervention:   Drug: Montelukast
Sponsor:   University of Colorado, Denver

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 17, 2022Comments | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine